Cargando…

Internet-based platform for a low-calorie dietary intervention involving prepackaged food for weight loss in overweight and obese individuals in China: protocol for a randomised controlled trial

INTRODUCTION: Obesity is a global health issue that impacts quality of life. A calorie-restricted diet with high-intensity consultation provided via the internet may be an effective way to lose weight. The objective of this study was to assess the effectiveness of a practitioner-guided, mobile inter...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xi, Wang, Suyuan, Zhang, Chenghui, Zhong, Lingyu, Lerman, Lilach, Lerman, Amir, Guo, Yanhong, Wu, Yunhong, Lopez-Jimenez, Francisco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785159/
https://www.ncbi.nlm.nih.gov/pubmed/35063952
http://dx.doi.org/10.1136/bmjopen-2020-048106
_version_ 1784638904023908352
author Wang, Xi
Wang, Suyuan
Zhang, Chenghui
Zhong, Lingyu
Lerman, Lilach
Lerman, Amir
Guo, Yanhong
Wu, Yunhong
Lopez-Jimenez, Francisco
author_facet Wang, Xi
Wang, Suyuan
Zhang, Chenghui
Zhong, Lingyu
Lerman, Lilach
Lerman, Amir
Guo, Yanhong
Wu, Yunhong
Lopez-Jimenez, Francisco
author_sort Wang, Xi
collection PubMed
description INTRODUCTION: Obesity is a global health issue that impacts quality of life. A calorie-restricted diet with high-intensity consultation provided via the internet may be an effective way to lose weight. The objective of this study was to assess the effectiveness of a practitioner-guided, mobile internet-based low-energy dietary intervention in overweight and obese populations in China. METHODS AND ANALYSIS: This open-label randomised controlled trial enrolled 220 overweight and obese adults aged 18–70 years who met the inclusion criteria. Participants were assigned to the control group (n=110) or trial group (n=110). The trial group will be enrolled in the MetaWell programme, a weight loss programme using diet replacement products, wireless scales and a mobile phone app. Participants in the control group will receive paper material containing a sample diet for weight loss. The follow-up period will be 1 year, and measurements will occur at 3, 6 and 12 months. Dual-emission X-ray absorptiometry and abdominal quantitative CT will be performed to estimate the percentage of overall body fat and areas of visceral and subcutaneous fat, alongside several cardiometabolic measurements. The primary outcome of this study is the change in body mas index (BMI) at 6 months after enrolment. A mixed-effects model will be used to compare BMI and body fat changes between the two groups. ETHICS AND DISSEMINATION: This study was approved by the ethics committee of the Hospital of Chengdu Office of the People’s Government of the Tibetan Autonomous Region. Advertisements for recruitment will be sent via official accounts using WeChat. The results will be disseminated via publications in academic journals and our clinic. Our study group will maintain contact with the participants to inform them of the study findings. TRIAL REGISTRATION NUMBER: ChiCTR1900021630.
format Online
Article
Text
id pubmed-8785159
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-87851592022-02-04 Internet-based platform for a low-calorie dietary intervention involving prepackaged food for weight loss in overweight and obese individuals in China: protocol for a randomised controlled trial Wang, Xi Wang, Suyuan Zhang, Chenghui Zhong, Lingyu Lerman, Lilach Lerman, Amir Guo, Yanhong Wu, Yunhong Lopez-Jimenez, Francisco BMJ Open Health Services Research INTRODUCTION: Obesity is a global health issue that impacts quality of life. A calorie-restricted diet with high-intensity consultation provided via the internet may be an effective way to lose weight. The objective of this study was to assess the effectiveness of a practitioner-guided, mobile internet-based low-energy dietary intervention in overweight and obese populations in China. METHODS AND ANALYSIS: This open-label randomised controlled trial enrolled 220 overweight and obese adults aged 18–70 years who met the inclusion criteria. Participants were assigned to the control group (n=110) or trial group (n=110). The trial group will be enrolled in the MetaWell programme, a weight loss programme using diet replacement products, wireless scales and a mobile phone app. Participants in the control group will receive paper material containing a sample diet for weight loss. The follow-up period will be 1 year, and measurements will occur at 3, 6 and 12 months. Dual-emission X-ray absorptiometry and abdominal quantitative CT will be performed to estimate the percentage of overall body fat and areas of visceral and subcutaneous fat, alongside several cardiometabolic measurements. The primary outcome of this study is the change in body mas index (BMI) at 6 months after enrolment. A mixed-effects model will be used to compare BMI and body fat changes between the two groups. ETHICS AND DISSEMINATION: This study was approved by the ethics committee of the Hospital of Chengdu Office of the People’s Government of the Tibetan Autonomous Region. Advertisements for recruitment will be sent via official accounts using WeChat. The results will be disseminated via publications in academic journals and our clinic. Our study group will maintain contact with the participants to inform them of the study findings. TRIAL REGISTRATION NUMBER: ChiCTR1900021630. BMJ Publishing Group 2022-01-21 /pmc/articles/PMC8785159/ /pubmed/35063952 http://dx.doi.org/10.1136/bmjopen-2020-048106 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Health Services Research
Wang, Xi
Wang, Suyuan
Zhang, Chenghui
Zhong, Lingyu
Lerman, Lilach
Lerman, Amir
Guo, Yanhong
Wu, Yunhong
Lopez-Jimenez, Francisco
Internet-based platform for a low-calorie dietary intervention involving prepackaged food for weight loss in overweight and obese individuals in China: protocol for a randomised controlled trial
title Internet-based platform for a low-calorie dietary intervention involving prepackaged food for weight loss in overweight and obese individuals in China: protocol for a randomised controlled trial
title_full Internet-based platform for a low-calorie dietary intervention involving prepackaged food for weight loss in overweight and obese individuals in China: protocol for a randomised controlled trial
title_fullStr Internet-based platform for a low-calorie dietary intervention involving prepackaged food for weight loss in overweight and obese individuals in China: protocol for a randomised controlled trial
title_full_unstemmed Internet-based platform for a low-calorie dietary intervention involving prepackaged food for weight loss in overweight and obese individuals in China: protocol for a randomised controlled trial
title_short Internet-based platform for a low-calorie dietary intervention involving prepackaged food for weight loss in overweight and obese individuals in China: protocol for a randomised controlled trial
title_sort internet-based platform for a low-calorie dietary intervention involving prepackaged food for weight loss in overweight and obese individuals in china: protocol for a randomised controlled trial
topic Health Services Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785159/
https://www.ncbi.nlm.nih.gov/pubmed/35063952
http://dx.doi.org/10.1136/bmjopen-2020-048106
work_keys_str_mv AT wangxi internetbasedplatformforalowcaloriedietaryinterventioninvolvingprepackagedfoodforweightlossinoverweightandobeseindividualsinchinaprotocolforarandomisedcontrolledtrial
AT wangsuyuan internetbasedplatformforalowcaloriedietaryinterventioninvolvingprepackagedfoodforweightlossinoverweightandobeseindividualsinchinaprotocolforarandomisedcontrolledtrial
AT zhangchenghui internetbasedplatformforalowcaloriedietaryinterventioninvolvingprepackagedfoodforweightlossinoverweightandobeseindividualsinchinaprotocolforarandomisedcontrolledtrial
AT zhonglingyu internetbasedplatformforalowcaloriedietaryinterventioninvolvingprepackagedfoodforweightlossinoverweightandobeseindividualsinchinaprotocolforarandomisedcontrolledtrial
AT lermanlilach internetbasedplatformforalowcaloriedietaryinterventioninvolvingprepackagedfoodforweightlossinoverweightandobeseindividualsinchinaprotocolforarandomisedcontrolledtrial
AT lermanamir internetbasedplatformforalowcaloriedietaryinterventioninvolvingprepackagedfoodforweightlossinoverweightandobeseindividualsinchinaprotocolforarandomisedcontrolledtrial
AT guoyanhong internetbasedplatformforalowcaloriedietaryinterventioninvolvingprepackagedfoodforweightlossinoverweightandobeseindividualsinchinaprotocolforarandomisedcontrolledtrial
AT wuyunhong internetbasedplatformforalowcaloriedietaryinterventioninvolvingprepackagedfoodforweightlossinoverweightandobeseindividualsinchinaprotocolforarandomisedcontrolledtrial
AT lopezjimenezfrancisco internetbasedplatformforalowcaloriedietaryinterventioninvolvingprepackagedfoodforweightlossinoverweightandobeseindividualsinchinaprotocolforarandomisedcontrolledtrial